Search research articles
Contact Us
Filters
Showing results (71-80 of 81) with videos related to
Page
of 9
Sort By:
Journal of Oncology
|
August 31, 2012
Radiolabeled somatostatin analogues therapy in advanced neuroendocrine tumors: a single centre experience
A Filice, A Fraternali, A Frasoldati, et al.
BMC Cancer
|
April 2, 2020
Searching for novel multimodal treatments in oligometastatic pancreatic cancer
D M Filippini, E Grassi, A Palloni, et al.
Journal of Endocrinological Investigation
|
March 22, 2000
Serum dehydroepiandrosterone sulfate (DHEA-S) and total antioxidant capacity (TAC) in healthy centenarian subjects
E Petruzzi, C Orlando, P Pinzani, et al.
Contrast Media & Molecular Imaging
|
October 27, 2018
Radiomic Profiling of Head and Neck Cancer: <sup>18</sup>F-FDG PET Texture Analysis as Predictor of Patient Survival
G Feliciani, F Fioroni, E Grassi, et al.
Europa Medicophysica
|
October 14, 2006
Quality of life and aphasia. Multicentric standardization of a questionnaire
L Posteraro, A Formis, E Grassi, et al.
Neuroscience Letters
|
August 29, 2000
Lack of SOD1 gene mutations and activity alterations in two Italian families with amyotrophic lateral sclerosis
D Gestri, C Cecchi, A Tedde, et al.
Neuroscience Letters
|
March 15, 1996
No evidence of linkage between schizophrenia and D2 dopamine receptor gene locus in Italian pedigrees
E Grassi, M Mortilla, L Amaducci, et al.
Biomed Research International
|
July 19, 2013
Kidney dosimetry in ¹⁷⁷Lu and ⁹⁰Y peptide receptor radionuclide therapy: influence of image timing, time-activity integration method, and risk factors
F Guerriero, M E Ferrari, F Botta, et al.
Computational and Mathematical Methods in Medicine
|
June 17, 2015
An Adaptive Thresholding Method for BTV Estimation Incorporating PET Reconstruction Parameters: A Multicenter Study of the Robustness and the Reliability
M Brambilla, R Matheoud, C Basile, et al.
ESMO Open
|
September 29, 2023
Phase II study of capecitabine-based concomitant chemoradiation followed by durvalumab as a neoadjuvant strategy in locally advanced rectal cancer: the PANDORA trial
E Grassi, C Zingaretti, E Petracci, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 81) with videos related to
Sort By:
Page
of 9
Journal of Oncology
|
August 31, 2012
Radiolabeled somatostatin analogues therapy in advanced neuroendocrine tumors: a single centre experience
A Filice, A Fraternali, A Frasoldati, et al.
BMC Cancer
|
April 2, 2020
Searching for novel multimodal treatments in oligometastatic pancreatic cancer
D M Filippini, E Grassi, A Palloni, et al.
Journal of Endocrinological Investigation
|
March 22, 2000
Serum dehydroepiandrosterone sulfate (DHEA-S) and total antioxidant capacity (TAC) in healthy centenarian subjects
E Petruzzi, C Orlando, P Pinzani, et al.
Contrast Media & Molecular Imaging
|
October 27, 2018
Radiomic Profiling of Head and Neck Cancer: <sup>18</sup>F-FDG PET Texture Analysis as Predictor of Patient Survival
G Feliciani, F Fioroni, E Grassi, et al.
Europa Medicophysica
|
October 14, 2006
Quality of life and aphasia. Multicentric standardization of a questionnaire
L Posteraro, A Formis, E Grassi, et al.
Neuroscience Letters
|
August 29, 2000
Lack of SOD1 gene mutations and activity alterations in two Italian families with amyotrophic lateral sclerosis
D Gestri, C Cecchi, A Tedde, et al.
Neuroscience Letters
|
March 15, 1996
No evidence of linkage between schizophrenia and D2 dopamine receptor gene locus in Italian pedigrees
E Grassi, M Mortilla, L Amaducci, et al.
Biomed Research International
|
July 19, 2013
Kidney dosimetry in ¹⁷⁷Lu and ⁹⁰Y peptide receptor radionuclide therapy: influence of image timing, time-activity integration method, and risk factors
F Guerriero, M E Ferrari, F Botta, et al.
Computational and Mathematical Methods in Medicine
|
June 17, 2015
An Adaptive Thresholding Method for BTV Estimation Incorporating PET Reconstruction Parameters: A Multicenter Study of the Robustness and the Reliability
M Brambilla, R Matheoud, C Basile, et al.
ESMO Open
|
September 29, 2023
Phase II study of capecitabine-based concomitant chemoradiation followed by durvalumab as a neoadjuvant strategy in locally advanced rectal cancer: the PANDORA trial
E Grassi, C Zingaretti, E Petracci, et al.
Page
of 9